Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Syrbe

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|July 26, 2000
T-cell trafficking into sites of inflammationA Hamann, U Syrbe
Zeitschrift Fur Rheumatologie|May 17, 2018
[Spondyloarthritis]U Syrbe, X Baraliakos
Zeitschrift Fur Rheumatologie|July 9, 2009
[Tissue retention of T cells as a therapeutic target in rheumatoid arthritis]U Syrbe, A Hamann
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?U Syrbe, J Siveke, A Hamann
Zeitschrift Fur Rheumatologie|October 15, 2013
[Epigenetic analyses - new therapeutic approaches for rheumatic diseases?]J K Polansky, U Syrbe, A Hamann
Scandinavian Journal of Rheumatology|May 1, 2015
In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controlsJ Bleil, R Maier, U Syrbe, et al.
Ernst Schering Research Foundation Workshop|October 29, 2003
Selectin ligands on T cellsA Hamann, U Syrbe, U Kretschmer, et al.
The Journal of Experimental Medicine|May 1, 1995
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor betaF Randow, U Syrbe, C Meisel, et al.
Nature Medicine|June 1, 1997
Monocyte deactivation in septic patients: restoration by IFN-gamma treatmentW D Döcke, F Randow, U Syrbe, et al.
Scandinavian Journal of Rheumatology|January 23, 2026
Soluble programmed cell death-1 is increased in axial spondyloarthritis and present at the local site of pathologyE Ahrenfeldt, M Hvid, A G Jurik, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|July 26, 2000
T-cell trafficking into sites of inflammationA Hamann, U Syrbe
Zeitschrift Fur Rheumatologie|May 17, 2018
[Spondyloarthritis]U Syrbe, X Baraliakos
Zeitschrift Fur Rheumatologie|July 9, 2009
[Tissue retention of T cells as a therapeutic target in rheumatoid arthritis]U Syrbe, A Hamann
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?U Syrbe, J Siveke, A Hamann
Zeitschrift Fur Rheumatologie|October 15, 2013
[Epigenetic analyses - new therapeutic approaches for rheumatic diseases?]J K Polansky, U Syrbe, A Hamann
Scandinavian Journal of Rheumatology|May 1, 2015
In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controlsJ Bleil, R Maier, U Syrbe, et al.
Ernst Schering Research Foundation Workshop|October 29, 2003
Selectin ligands on T cellsA Hamann, U Syrbe, U Kretschmer, et al.
The Journal of Experimental Medicine|May 1, 1995
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor betaF Randow, U Syrbe, C Meisel, et al.
Nature Medicine|June 1, 1997
Monocyte deactivation in septic patients: restoration by IFN-gamma treatmentW D Döcke, F Randow, U Syrbe, et al.
Scandinavian Journal of Rheumatology|January 23, 2026
Soluble programmed cell death-1 is increased in axial spondyloarthritis and present at the local site of pathologyE Ahrenfeldt, M Hvid, A G Jurik, et al.
Pageof 2